Recent Updates
Recently added Catalysts
ANGO Positive Sentiment

AngioDynamics to Participate in Upcoming Investor Conferences

Tuesday, July 28, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: AngioDynamics, Inc. (NASDAQ: ANGO) has announced its participation in several upcoming investor conferences, including the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference. This engagement reflects the company's commitment to connect with investors and stakeholders. The focus on restoring healthy blood flow and expanding cancer treatment options is central to their mission.
Price reaction · baseline $13.66 (2026-07-27 close) · hit pre-market · clean, no other ANGO news in the window
day 0 close · peak
+5%

Market Sentiment Analysis

POSITIVE FACTORS

  • AngioDynamics is actively engaging with investors.
  • Participation in multiple conferences highlights company growth.
  • Focus on improving patient quality of life is commendable.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~6 mo
Medium dilution risk
Lead asset
RF ablation
Phase 2 · Non Small Cell Lung Cancer

Full Press Release Details

AngioDynamics to Participate in Upcoming Investor Conferences

LATHAM, N.Y.--(BUSINESS WIRE)--Jul. 28, 2026--AngioDynamics, Inc.(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that its management team is scheduled to participate in the following upcoming investor conferences:

11thAnnual Needham Virtual MedTech & Diagnostics 1x1 ConferenceMonday, August 10, 2026

Canaccord Genuity's 46thAnnual Growth ConferencePresentation:Tuesday, August 11, 2026from3:30-3:55 PM ETA live webcast of the presentation will be accessible through the “Investors” section of the Company’s website atwww.angiodynamics.com.

About AngioDynamics, Inc.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.
The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visitwww.angiodynamics.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20260728796556/en/
Investors:Stephen TrowbridgeExecutive Vice President & CFO518-795-1408strowbridge@angiodynamics.com
Media:Saleem CheeksVice President, Communications518-795-1174scheeks@angiodynamics.com
Source: AngioDynamics, Inc.

Frequently Asked Questions

What conferences will AngioDynamics participate in?

AngioDynamics will participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference.

What is the focus of AngioDynamics?

AngioDynamics focuses on restoring healthy blood flow and expanding cancer treatment options.

When is the Needham Virtual Conference scheduled?

The Needham Virtual MedTech & Diagnostics 1x1 Conference is scheduled for August 10, 2026.

What is the ticker symbol for AngioDynamics?

The ticker symbol for AngioDynamics is NASDAQ: ANGO.

ShareAdd on Google
Tags: ANGO AngioDynamics investor conferences medical technology NASDAQ: ANGO patient care
Last updated: Jul 28, 2026

Biotech snapshot

Cash runway
$34M liquidity · $5M/mo burn
~6 mo
Medium dilution risk
Lead asset
RF ablationPhase 2
Non Small Cell Lung Cancer →